Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The news item today vs the news item last night...= Something strange is taking place.
Todays news item is clearly "Looking forward news"
With really o meat to hang your hat on..
Could potentially provide.......Could, maybe, might...not sure if it will..ect...
All left to chance....Comic irony gods..
I'm thinking Neurochem is hiding something.....like a buyout offer from a huge giant in the industry.
If they are so sure that in the near future, they can produce real cash flow from one of their drugs..why won't they try and sell that to a giant firm in the industry who needs new drugs.
Its kinda odd...
Up in after hours trading to.."Trap" those who dot know better.
Who do you think makes those trades in after hours?
MM's do...
AS the shares drop in value...they gain money..or create money.
The mm's took the shares up soooo slowly..like the water temperature while a frog boils to death without jumping out.
Then they hit us with more negative news...
Down goes the value...
Who gains?
the mm's and the company gains.
Bull trap at its best..
I just checked the overnight Bid side of the equationthey are bidding $1.04 per share..the open is going to be ugly.
The $.58 per share is looking pretty interesting now..with Neurochem reporting more losses...
Wall Street is not going to be very happy thursday...
You are 100% correct//
Adolf Coors III was the former heir to the Coors beer empire, (Ironically) Mr. Coors was ALLERGIC to beer.
How funny and odd.....
Basketball Star "Pistol" Pete Maravich told a Pennsylvania reporter, "I don't want to play 10 years (In the NBA) and then die of a heart atk when I'm 40."
Comic irony In 1988 he collapsed and died of a heart attack at ag 40, after playing exactly 10 NBA seasons.
How tragic and strange.....
Thursday to Friday trading we might see it breakout either lower or higher.....
They even might what until next week..
The general markets are selling off..so it may not be wise idea to try and bring out any trading news..
The elements of contrast between Placebo results and the drug results are pretty close......05% Pvalue
Maybe Neurochem can market the first Placebo drug.
I just can't understand how the patients will remember to take their medicine....
Or even remember to purchase it...
Selling a product that people can't remember seems odd.
Serious question to being able to climb (through) the overhead supply area.....
Fact remains all of their past history results in testing have come up short in terms of passing grades.
They can't even pass the P-Value .05% test mark.
The FDA is trying to lean their way by just saying "Please just show us at least .05% P-Value results from your tests."
Ironically, Neurochem Inc. Management is forgetting so much.
Adolph Coors 111 was the former heir to the Coors beer empire...But he never once drank his own beer product.
This is true...
Does anyone know why he refused to drink his own Coors beer?
Surewipes Inc. shareholders converted over to ONYY shares..this is true....
But Biopulse International shareholdes (Common shareholders) are not converting over to ONYY..
Biopulse Inc. sold its OTCBB shell only for $18,000
To Mario...
Mario can't pay $18,000 for a OTCBB shell and obtain a $48,000,000 new technology and over $4,500,000 in cash.
The recognition of ambiguities and often equivocations and unstated assumptions underlying known PARADOXES has LED to Significant advances in the medical field...as well as the sciences.
But also many PARADOX, do not yet have universally accepted resolutions......
So the Jeffreys-Lindley Paradox within Kiacata drug testing data...might led to a major breakthrough in brain barrior problem.
Curry's Paradox is one such Paradox that has yet to gain universally accepted resolutions.
With 200 of the worlds best and britest scientist at Neurochem reach...lets pray they have figure out somekind of magic trick.
Your 100% correct...I should not single out just the FDA.
For using the P-value of .05
Jeffreys- Lindley Paradox....is something very interesting..
And it may apply to the data findings of the Kiacata drug.
The major significance of the drug testing should not be determined by the P-value at all...it should be by the agents interpreting the data before the data are viewed, and is compared against the p-value or any other statistic calculated after the test has been performed..
The P-value doe snot indicate the size or importance of the observed effect...compared with effect size.
There are many frequent misunderstandings about P-value usage...
This drug is really needed in my opinion....as long as there is no real bad side effects..which so far the testing results havn't displayed.
The public needs this drug now...
I may have beenlittle hard on the FDA....your right...I stand corrected...
Thanks good luck
REmember UBS still has their downgrade on Neurochem and as of August 2007 they lower it from $4.50 to $1.00 per share.
So If i'm clueless then UBS top paid advisors must be what?
$1.00 per share is not far from $.58
Last time Neurochem shares went to $7.50 just before the news was released...then the floor fell out..and it tanked to $2.12
So before you surf call me names like clueless..
You better remember prices don't go in a straight line..
Overhead supply starts at $5.00 level....
FDA is only asking for P-Value of .05 from the testing results.
What they really should be asking for is P-Rep Value...
P-Rep Value is Certain proability that an effect can be replicated.
Its really a no brainer that Neurochem is going to get the green light with drug....the FDA is a joke...
The FDA is place to protect the public......right..thats been changed.
Getting a drug passed through the fDA with P-value of .05 is simple..
Not even a issue....
I really feel most drugs might be pure water and sugar..
Random blind fold testing..pass the test with P-value of .05
See everyone at $7.50 soon
July 17, 2007 Action Letter from the FDA clearly did state "Neurochem drug Kiacta did provide some evidence to help treat people with their problems.."
FDA wanted more study regarding EFFECTIVENESS of the drug.
With their subjective nature EFFICACY TRIAL P-Value rating of .05.
now there are strong CRITICS who refuse to take the P-Value rating of .05 as STATISTICAL SIGNIFICACE..
1. The p-value is NOT the probability that the null hypothesis is true.
Nor is it a finding that its a MERELY FLUKE..
So in debt study or knowledge of the P-Value system...
no real clear assumptions can be made..I'm 100% sure the FDA understands this....truth of knowledge.
So without going to indebt...I'm 100% sure the FDA is going to give the green light based not on the P-value results alone..but more based on the agents who interpret the data and compare those findings against the statistic calculated after the test have been performed.
When dealing with the human body....the outcomes from these trials are very complex in nature.
FDA using the .05 P-value as their standard is very low..and generally speaking the smaller the p-value the more people who will tend and be willing to say that the results came from a biased test results..
Interpretation from the investment world..is something to be seen.
10:30 am to close is certainly going to take our normal rhythm of breathing away.
You must be present to win................
I feel someone is very short going into these last few hours.
And they will try and cover...
10:00 am Money Flow Index shot upwards to over 70 reading on the 10 minute chart....
Then last trade was $3.79
Money flow shot downward sharply.....
This puppy is going to explode upwards above $4.00
9:55 am Someone is selling short within the last 5 minutes
Monday someone sold short 20,000 shares and then bang the price took off in the upwards directions..
Very interesting trading today..
Monthly MACD suggests the larger trend is still upwards...
Weekly MACD at - 1.3142 at $3.85 per share level suggests upwards is the trend.
Daily MACD suggests upwards is the trend.
The hourly MACD is really exciting signal...
+.03144 reading at $3.85 price level....
Probability reading on the hourly suggests one should long now..and we could make a move soon..
whenever the thermostat regulating the temperature of the circle of fire is set low.....it means that that which it protects is of inferior value.
life has never been known to lessen the guard around the really big rewards.
Daily float is low... I have tried buying above the asking price today...they don't want to sell..
If its hard to buy..then its going higher..
news may be coming out..good luck
Study have proven the drug don't work....its has no real value to the person or persons in need.
But with the current leaders in control of the FDA and drug industry....they will allow this new drug to hit the consumer market because of two reasons...Johnson and Johnson has placed a lot of capital into Neurochem...and there is currently no drug available to market..
So in my humble opinion, the new drug will win the green light from the FDA..based on those factors alone.
The current chart pattern suggests somekind of large movement to either the upside or downside..but I'm leaning toward the upside on this one for now.
So place your bets....
If this news item that about to come forth, is good...look for a retest of $7.50 per share level.
If the news is bad..a new low of $.98 is coming..
So its a high risk play.....
Risk to reward?
Best of luck....
Biopulse shares are a separate common shares....Biopulse International Inc. sold its Biopulse Inc shell OTCBB to Mario..
Mario group tried to confused the Biopulse shareholders into selling their shares to him..
Superwipe and ONYY has nothing to do with Biopulse shares.
So if I don't post your views, I'm going to be banned..
Thats a free society of exchange..
Since I feel this company stock is going to $.58 I'm going to get banned...
This is a open reply back to a private message that is threating in nature..
Freedom of speech is not here..beware
10,000 shares short covering this morning...don't make for no long term gains..it makes for for a trap..
Remember they have bills to pay each month..
No product driven way of making money..so the mm's sell short..then cover.....with these traps..
Day traders provide what?
A. Capital
B. working funds
After hour trading has really never been large in nature in volume...with this stock...
If anything Afterhours is very light volume....
The current price truly relects the selling of shares to raise working capital..end of the month rent bills ect...
This company has no product driven way of obtaining revenue to pay bills....it has to sell shares to raise capital.
We are entering November still no results from their drug testing.....
$26.00 to the current $3.58 price level...
And you don't think they are selling shares to raise capital?
We are only 3 points from $.58 per share..
Broke support..so the next level will be the $2.50 mark.
If it can't hold $2.50 level..we are going to test $1.50 level.
Most likely this stock is going lower to say $.50 levels.
They need working capital..so they r selling shares to raise needed cash..
So If you feel they can solve the FDA requests ina year of less..just ride it down...down down..
In the long run you will gain back what you loss.
Roche is trying to purchase VMSI..and can't get them...
I'm thinking we r about to get ahuge offer from some giant..
todays open will be interesting......gap open maybe
its the season forlarge firms to purchase new technology.
What strikes me odd, Is the elimination criteia between the transition period of drug performance during testing in phase 3 trials and the abrupt offering by Johnson & Johnson to take control of the drug future profits ($54,000,000) deal....and the Pfizers rumors.....
In essence, the paradox here is really a riddle within a circle of powerful giants.....positioning for power.
In the endgame, of things to come to maintain an unwavering faith for the management to prevail despite the brutal facts. this duality of bi-polar thoughts.
Leaves even the sharpest investor puzzled in regards to the out future outcome results.
Maybe thats exactly how the investment bankers want it...
reviewing over all of the trades its interesting trades over the last 8 week period...
Strong steady accumlation is in full effect (8 weeks and counting) very odd.
Its like someone knows something....
Just on the 8 weeks trading pattern..I suspect something huge is coming out...
$2.12 to $4.00 range is 100% gain..
Those who bought in the last 8 weeks are making good money..
warner lambert fell into the warm arms of Pfizer many years ago.
Pfizer management has that keen eye for attracting just the right new technology at just the perfect time.
Pfizer would obtain $80,000,000 in cash and obtain certain key new drug technology If they considered buying Neurochem inc.
They may be eyeing th deal..but I think Pfizer might wait....before taking the bold step...
At www americanbulls.com website their computer model posted a HOLD today for Neurochem Inc.
Its getting exciting...
2007 Breeders Cup Championships starts Friday thru Saturday...
The only horse I would bet on is cherokee Triangle 10 to 1 odds in the 2 year old race...
Neurochem $2.00 ticket might fetch $26.00
Horse racing your money is history in less than 1 minute and 46 seconds...at least here t takes months..
To be honest with your question who's running thi stock? I really don't know.....
But the Onbalance indicator today...is pointing to the bull camp.
Someone is trying to pickup shares at current levels...
Why is the nequestion....
low volume today..lots of green...
I still feel the FDA will give the green light soon to the Kiacta drug..just because their is no other drug available...
November 2007 Issue of Readers Digest has a very interesting story on pages 105 to 113
Neurochem is looking good in my book today..in terms of the fundamentals and technicals....
July 16, 2007 Neurochem Inc. released a news item in regards to their Kiacta drug progress....its on their website under news items....
I'm still feeling with todays buy side inbalance someone is getting ready to release some news...
Its just awesome chart patten we have currently....its chances of blasting off to anyones wildest dreams levels is there.....plain as day....
The negative bias is felt in the stock price currently....
Any powerful positive bias...will propel this stock to higher levels ina flash......
I hope this helps to answer your question..I just don't have a clue right now who is in control...
I just feel we are sooooo oversold right now at current levels.
We need some powerful positive news....to propel it above $6.00
Prince Charles sits on the BOARD of DIRECTORS of Citigroup and also sits on the board of directors of Johnson N Johnson who gave $40,000,000 to NRMX recently...through their sub company..
Thats awesome news..
Buyout could be in the works..and outsiders could run the price up just on the betting side of the equation
Kiacta Drug should be getting the green light soon.
I'm thinking the insiders are buying up shares at dirt levels...
Part of the (Concealment) advantage the company holds over the outsiders.
Psychological tactics used by most companies is nor should organizations make obious their advantages.
The first success step is to conceal any advantages....
Kiacta drug was slated for April 16...its been moved back three months to July 2007 and still no word....
I know (Hedgehog) comcept Johnson N Johnson wants their hands of this unique powerful drug...
If we get the green light....watch out $26 plus..
Go NRMX
Observation 9:40 am..
The general markets are selling off (correction) BUT Neurochem Inc. (Our) puppy is rising against the tide....this is a good positive sign...for future prices to continue higher in my book of knowledge.
Awe!! that Success adventure...that we all want to obtain in this life....Someone once said " Calculated risk-taking is living"
Life without risk is merely existing.
There's no comparison between what's lost by not trying and what's lost by not succeeding.---Francis Bacon
This company reminds me of the 2000 BYU vs Virgina football game...Virgina was ahead at half time 21 to 0 over BYU....
BYU team went into the locker room down 21 points....coach Lavell Edwards of BYU gave his speech talk to his team players after he had consulted with his team advisors on what they were doing wrong....
Neurochem Inc. is doing the exact samething..consulting with their advisors why their drugs are failing to pass the FDA tests...
BYU came out after halftime and won the game .....
It was one of the greatest VICTORY of coach Lavell Edwards coaching years at BYU...it was his last year he coached he turned 70 that year.....
Its half time..Neurochem Inc. is down...by its high of 26 to $2.12 lowest point ever...thats 24 points..
I'm thinking they can do it.......
Go NRMX......
White Spinning Top Candlestick Pattern was formed today..
It means (Indecision) between both the Bear camp and Bull camp....
But the last two trading days before todays....a Very Bullish reversal pattern has been formed..called Bullish Harami Pattern...which means (reversal) or trend change...
After hours the stock is up.....
So we do have some signs of a trend change might be present.
If only we could get some powerful good news....to help fuel some confidence in the drug side of the equation.
I feel strongly, we are still very much oversold..in respect to the future products that might come forth.
I thought I would post these observations...to those who care.
One more test of support....we should hear from the company soon.
News
Investors hearts have hardened toward buying.....
To preserve the confidence of their investors, they better feed them some good news soon....eos
Stock Chart pattern....WTRO..
Ending Diagonal Triangle....one of the rarest pattern.
Simple premise of this awesome pattern..is the price continues to drop...until somekind of huge infusion of capital comes into play...revenue from sales...ect....
Earnings......surprise....
So the Mystery is did Wi_tron inc...makes any money?
I don't think anyone is buying up shares..
The sales from their (Products) revenue must be accounted for.
The company insiders can't take any funds out of a company unless they own shares.
As the company places its earnings into the stock..the price rises...
We should be rising to new highs..IF sales were good.
zoro5304 They said it in the august 26 conference call meeting.
One of the mutual fund managers then asked "How come the FDA knew" the Neurochem advisory didn't respond back.
He just said we have (options)
i'm thinking they are going to review all of the test results and review the FDA reports....then change their drug recipeto fit the FDA trials....
If u read their website very closely..options is used..
I think they just want to flush out the weaker hands..
JNJ sub firm gave them $40 million..why?
and they also said "Those investors who hold with them long term would reap rewards"
$2.12 seem to be thefloor....
$2.00 to $12.00 = 500% return on their investment dollar.
If they took i tup at $6.00 to $12.00 they would only make 100% return.
So its in their best interest to crush it low..
God bless